4/A//SEC Filing
Downey Gregory 4/A
Accession 0001855763-22-000020
CIK 0001348362other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 6:31 PM ET
Size
14.0 KB
Accession
0001855763-22-000020
Insider Transaction Report
Form 4/AAmended
Downey Gregory
Chief Financial Officer
Transactions
- Purchase
common shares
2022-10-14$2.09/sh+121$253→ 1,954 total
Holdings
- 8,000
Stock Options
Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 25,000
Stock Options
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (8,000 underlying) - 46,000
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (11,000 underlying) - 4,000
Stock Options
Exercise: $5.04From: 2021-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 1,833
common shares
- 12,000
Stock Options
Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 17,000
Stock Options
Exercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying) - 35,000
Stock Options
Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying)
Footnotes (1)
- [F1]This Form 4A is being filed to correct the transaction code for the open market purchase made by Mr. Downey as originally notated as a grant or award in the Form 4 filed on October 18, 2022.
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001855801
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 6:31 PM ET
- Size
- 14.0 KB